Head-to-head · Value Score
bmiMD vs Invigor Medical
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Invigor Medical a 82. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#8 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameInvigor Medical
#19 · Grade B+ · Good Value
Est. first month
$199/mo
Save ~85% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 82 — an est. $99/mo first month, with no teaser step-up baked in. Invigor Medical isn't out of it: People who want GLP-1 pricing they can see up front alongside a wider wellness/hormone catalog.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Invigor Medical |
|---|---|---|
| Value Score | 89 (A) | 82 (B+) |
| Est. first month | $99/mo | $199/mo |
| Save vs brand-name | ~93% | ~85% |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $139/mo | $339/mo |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | Not disclosed |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Invigor Medical
Mid-market flat pricing on both molecules from a long-running, broad-catalog operator.
Why it's a deal
- Both molecules priced up front
- Long-running operator with a broad catalog
- No known teaser-rate tier
The fine print
- Tirzepatide ($339) runs pricier than the best deals
- Does not publish an explicit states-served list
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.